NasdaqGM - Nasdaq Real Time Price USD
Xencor, Inc. (XNCR)
7.99
-0.47
(-5.61%)
At close: May 7 at 4:00:00 PM EDT
8.61
+0.62
+(7.83%)
Pre-Market: 5:19:31 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 10 |
| Avg. Estimate | -0.85 | -0.87 | -3.26 | -2.46 |
| Low Estimate | -0.92 | -0.98 | -3.57 | -3.29 |
| High Estimate | -0.77 | -0.76 | -2.88 | -1.48 |
| Year Ago EPS | -1.07 | -0.71 | -3.58 | -3.26 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 11 |
| Avg. Estimate | 19.09M | 20.67M | 95M | 144.41M |
| Low Estimate | 10M | 10M | 70M | 78.35M |
| High Estimate | 23.73M | 29.66M | 118.76M | 342.88M |
| Year Ago Sales | 16.96M | 10.71M | 110.49M | 95M |
| Sales Growth (year/est) | 12.58% | 92.96% | -14.02% | 52.01% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.79 | -1.02 | -0.79 | -0.58 |
| EPS Actual | -1.07 | -0.71 | -0.62 | -0.66 |
| Difference | -0.28 | 0.31 | 0.17 | -0.08 |
| Surprise % | -35.83% | 30.42% | 21.14% | -13.61% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.85 | -0.87 | -3.26 | -2.46 |
| 7 Days Ago | -0.65 | -0.67 | -2.68 | -2.43 |
| 30 Days Ago | -0.67 | -0.68 | -2.63 | -2.36 |
| 60 Days Ago | -0.67 | -0.68 | -2.63 | -2.36 |
| 90 Days Ago | -0.86 | -0.87 | -3.09 | -2.55 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 1 |
| Up Last 30 Days | 1 | 1 | 2 | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| XNCR | 20.11% | -22.44% | 9.00% | 24.58% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Initiated | William Blair: Outperform | 4/21/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 2/28/2025 |
| Initiated | Wells Fargo: Overweight | 12/12/2024 |
| Upgrade | Piper Sandler: Neutral to Overweight | 12/2/2024 |
| Reiterates | BMO Capital: Outperform to Outperform | 11/8/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 11/7/2024 |
Related Tickers
ANAB AnaptysBio, Inc.
19.68
-2.19%
SYRE Spyre Therapeutics, Inc.
12.71
+1.60%
KURA Kura Oncology, Inc.
5.65
-2.50%
BCYC Bicycle Therapeutics plc
7.78
+5.14%
AGIO Agios Pharmaceuticals, Inc.
28.22
-0.35%
RVMD Revolution Medicines, Inc.
37.66
+0.59%
VRDN Viridian Therapeutics, Inc.
12.29
+2.16%
NRIX Nurix Therapeutics, Inc.
9.30
-3.58%
MGNX MacroGenics, Inc.
1.4900
+1.36%
XENE Xenon Pharmaceuticals Inc.
35.33
+0.43%